Chronic nitrates blunt the effects of not only nitric oxide but also natriuretic peptides in cardiac myocytes

Pharmacological Research

Volumn 56, Issue 1, 2007, Pages 49-55

  Tan, Tao ^a   Zhang, Qihang ^a   Anyadike, Chukwuma ^a   Scholz, Peter M ^a   Weiss, Harvey R ^a  

^a University of Medicine and Dentistry   (United States)

Author keywords

Cardiac myocyte function; Natriuretic peptides; Nitric oxide; Nitroglycerin patch; Rabbit

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; GUANYLATE KINASE; KT 5823; N ACETYL S NITROSOPENICILLAMINE; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; NITRIC ACID DERIVATIVE; NITRIC OXIDE; PHOSPHOPROTEIN; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEART MUSCLE CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RABBIT;

ANIMALS; CARBAZOLES; CELL SIZE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANYLATE CYCLASE; INDOLES; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; NATRIURETIC PEPTIDES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROGLYCERIN; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RABBITS; S-NITROSO-N-ACETYLPENICILLAMINE; TACHYPHYLAXIS;

EID: 34250794653     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.03.005     Document Type: Article

References (29)

1. Murad F. Cellular signaling with nitric oxide and cyclic GMP. Braz J Med Biol Res 32 (1999) 1317-1327
2. Shah A.M., and MacCarthy P.A. Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther 86 (2000) 49-86
3. Chung K.K., Dawson T.M., and Dawson V.L. Nitric oxide, S-nitrosylation and neurodegeneration. Cell Mol Biol 51 (2005) 247-254
4. Munzel T., Daiber A., and Mulsch A. Explaining the phenomenon of nitrate tolerance. Circ Res 97 (2005) 618-628
5. Needleman P., and Johnson Jr. E.M. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 184 (1973) 709-715
6. Mulsch A., Oelze M., Kloss S., Mollnau H., Topfer A., Smolenski A., et al. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation 103 (2001) 2188-2194
7. Sage P.R., de la Lande I.S., Stafford I., Bennett C.L., Phillipov G., Stubberfield J., et al. Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion. Circulation 102 (2000) 2810-2815
8. Agvald P., Hammar L., and Gustafsson L.E. Nitroglycerin-patch induced tolerance is associated with reduced ability of nitroglycerin to increase exhaled nitric oxide. Vasc Pharmacol 43 (2005) 449-457
9. Kim D., Rybalkin S.D., Pi X., Wang Y., Zhang C., Munzel T., et al. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation 104 (2001) 2338-2343
10. Gori T., and Parker J.D. Nitrate tolerance: A unifying hypothesis. Circulation 106 (2002) 2510-2513
11. Gori T., and Parker J.D. The puzzle of nitrate tolerance: pieces smaller than we thought?. Circulation 106 (2002) 2404-2408
12. Daiber A., Oelze M., Coldewey M., Bachschmid M., Wenzel P., Sydow K., et al. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol 66 (2004) 1372-1382
13. Baxter G.F. Natriuretic peptides and myocardial ischaemia. Basic Res Cardiol 99 (2004) 90-93
14. Su J., Tse J., Scholz P.M., and Weiss H.R. Alterations in ventricular myocyte contraction caused by C-type natriuretic peptide and nitric oxide in eNOS-/- mice. J Mol Cell Cardiol 39 (2005) 920-928
15. Zhang Q., Molino B., Yan L., Haim T., Vaks Y., Scholz P.M., et al. Nitric oxide and cGMP protein kinase activity in aged ventricular myocytes. Am J Physiol 281 (2001) H2304-H2309
16. Sadoff J.D., Scholz P.M., Tse J., and Weiss H.R. Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3′5′-monophosphate in left ventricular hypertrophy. J Clin Invest 98 (1996) 838-845
17. Agullo L., Garcia-Dorado D., Escalona N., Ruiz-Meana M., Inserte J., and Soler-Soler J. Effect of ischemia on soluble and particulate guanylyl cyclase-mediated cGMP synthesis in cardiomyocytes. Am J Physiol 284 (2003) H2170-H2176
18. Andreka P., Tran T., Webster K.A., and Bishopric N.H. Nitric oxide and promotion of cardiac myocyte apoptosis. Mol Cell Biochem 263 (2004) 35-53
19. Barreiro E., de la P.B., Minguella J., Corominas J.M., Serrano S., Hussain S.N., et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 (2005) 1116-1124
20. Sabri A., Hughie H.H., and Lucchesi P.A. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal 5 (2003) 731-740
21. D'Souza S.P., Davis M., and Baxter G.F. Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther 101 (2004) 113-129
22. Munzel T., Sayegh H., Freeman B.A., Tarpey M.M., and Harrison D.G. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 95 (1995) 187-194
23. Dikalov S., Fink B., Skatchkov M., Stalleicken D., and Bassenge E. Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrate in vitro and development of nitrate tolerance. J Pharmacol Exp Ther 286 (1998) 938-944
24. Warnholtz A., Tsilimingas N., Wendt M., and Munzel T. Mechanisms underlying nitrate-induced endothelial dysfunction: insight from experimental and clinical studies. Heart Fail Rev 7 (2002) 335-345
25. Abou-Mohamed G., Johnson J.A., Jin L., El Remessy A.B., Do K., Kaesemeyer W.H., et al. Roles of superoxide, peroxynitrite, and protein kinase C in the development of tolerance to nitroglycerin. J Pharmacol Exp Ther 308 (2004) 289-299
26. Schulz E., Tsilimingas N., Rinze R., Reiter B., Wendt M., Oelze M., et al. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation 105 (2002) 1170-1175
27. Su J., Zhang Q., Moalem J., Tse J., Scholz P.M., and Weiss H.R. Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts. Am J Physiol 288 (2005) H1367-H1373
28. Brusq J.M., Mayoux E., Guigui L., and Kirilovsky J. Effects of C-type natriuretic peptide on rat cardiac contractility. Br J Pharmacol 128 (1999) 206-212
29. Nir A., Zhang D.F., Fixler R., Burnett Jr. J.C., Eilam Y., and Hasin Y. C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes. Eur J Pharmacol 412 (2001) 195-201